{"prompt": "['Date and Version No: 7 19/12/19', '21.', 'APPENDIX C: SCHEDULE OF PROCEDURES', 'Procedures', 'Visits', 'Screening', 'Baseline', 'Follow-up', 'Qualitative', 'Windows', 'arm', 'Informed consent', 'x', 'X', '1 month', 'Screening MoCA', 'X', '1 month', 'Demographics', 'X', 'X', 'x (carers)', '1 month', 'Medical history', 'X', 'X', '1 month', 'Concomitant', 'X', 'X', '1 month', 'medications', 'Eligibility assessment', 'X', 'N/A', 'Randomisation', 'X', '4-6 weeks', 'Compliance', 'X', 'X', 'N/A', 'Cognition (ACE-III)', 'X', 'X', 'Baseline: 4-6 weeks,', 'Follow-up: 8-12', 'weeks from', 'randomisation', 'Mood (GDS)', 'X', 'X', 'Baseline: 1 month,', 'Follow-up: 8-12', 'weeks from', 'randomisation', 'Edinburgh', 'handedness', 'X', 'Baseline: 1 month,', 'Inventory', 'Follow-up: 8-12', 'weeks from', 'randomisation', 'Function (Lawton-IADL)', 'X', 'X', 'Baseline: 1 month,', 'Follow-up: 8-12', 'weeks from', 'randomisation', 'Quality', 'of', 'Life', 'X', 'X', 'Baseline: 1 month,', '(DEMQOL)', 'Follow-up: 8-12', 'weeks from', 'randomisation', 'Neurovascular function', 'X', 'X', 'Baseline: 4-6 weeks,', '(TCD, blood pressure,', 'Follow-up: 8-12', 'ECG, ETCO2', 'weeks from', 'randomisation', 'Adverse event', 'X', 'N/A', 'assessments', 'CONFIDENTIAL', 'Page 55 of 57', 'The Cognition and Flow Study']['Date and Version No: 7 19/12/19', 'Telephone Support', 'X', 'Weekly telephone', 'X', '(intervention arm only)', 'support to', 'participants in', 'intervention arm.', 'Qualitative', 'x', 'At least 1 week', 'interview/focus group', 'after trial', '(optional)', 'completion', 'CONFIDENTIAL', 'Page 56 of 57', 'The Cognition and Flow Study']['Date and Version No: 7 19/12/19', '22.', 'APPENDIX D: EXPECTED EVENTS NOT SUBJECT TO EXPEDITED REPORTING', 'Acute Coronary Syndromes', 'Malignancy', 'Agitation', 'Myocardial infarction', 'Angina', 'Nausea', 'Anorexia', 'Personality change', 'Anxiety', 'Peripheral Vascular Disease', 'Cognitive decline', 'Pressure sores', 'Constipation', 'Renal impairment', 'Delirium', 'Sedation', 'Depression', 'Seizure', 'Disease progression', 'Sexual dysfunction', 'Dysphagia', 'Sleep disturbance', 'Electrolyte disturbance', 'Stroke', 'Fall', 'Syncope', 'Fatigue', 'Transient ischemic attack', 'Fracture', 'Urinary retention/catheterisation', 'Gastrointestinal disturbance', 'Urinary tract infection', 'Hallucinations', 'Ulceration', 'Heart failure', 'Violent behaviour', 'Incontinence, faecal', 'Visual loss', 'Incontinence, urinary', 'Vomiting', 'Infections', 'Wandering', 'Institutionalisation / Admission to care home', 'Weakness', 'Intracerebral Haemorrhage', 'Weight loss', 'Loss of ability to function or care for self', 'CONFIDENTIAL', 'Page 57 of 57', 'The Cognition and Flow Study']\n\n###\n\n", "completion": "END"}